CN105664068A - Traditional Chinese medicine composition for treating cervical spondylosis - Google Patents
Traditional Chinese medicine composition for treating cervical spondylosis Download PDFInfo
- Publication number
- CN105664068A CN105664068A CN201610238227.9A CN201610238227A CN105664068A CN 105664068 A CN105664068 A CN 105664068A CN 201610238227 A CN201610238227 A CN 201610238227A CN 105664068 A CN105664068 A CN 105664068A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 206010041591 Spinal osteoarthritis Diseases 0.000 title claims abstract description 20
- 208000036319 cervical spondylosis Diseases 0.000 title claims abstract description 19
- 208000005801 spondylosis Diseases 0.000 title claims abstract description 19
- 239000009636 Huang Qi Substances 0.000 claims abstract description 10
- 241000522620 Scorpio Species 0.000 claims abstract description 10
- 239000009490 scorpio Substances 0.000 claims abstract description 10
- 244000285790 Cyperus iria Species 0.000 claims description 9
- 241001489978 Eupolyphaga Species 0.000 claims description 9
- 210000000988 bone and bone Anatomy 0.000 abstract description 12
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 4
- 206010047700 Vomiting Diseases 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 206010011878 Deafness Diseases 0.000 abstract description 3
- 206010050296 Intervertebral disc protrusion Diseases 0.000 abstract description 3
- 208000009205 Tinnitus Diseases 0.000 abstract description 3
- 231100000895 deafness Toxicity 0.000 abstract description 3
- 208000016354 hearing loss disease Diseases 0.000 abstract description 3
- 231100000886 tinnitus Toxicity 0.000 abstract description 3
- 206010047513 Vision blurred Diseases 0.000 abstract description 2
- 208000029078 coronary artery disease Diseases 0.000 abstract description 2
- 241000559228 Bolboschoenus yagara Species 0.000 abstract 1
- 235000006463 Brassica alba Nutrition 0.000 abstract 1
- 244000140786 Brassica hirta Species 0.000 abstract 1
- 235000011371 Brassica hirta Nutrition 0.000 abstract 1
- 230000036770 blood supply Effects 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
- 210000002385 vertebral artery Anatomy 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010005963 Bone formation increased Diseases 0.000 description 2
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004409 osteocyte Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 208000029761 vertebral disease Diseases 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010031264 Osteonecrosis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 201000006559 Vertebrobasilar insufficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000002670 chondrogenetic effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 201000005848 vertebral artery insufficiency Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating cervical spondylosis. The traditional Chinese medicine composition comprises, by weight, 25-35 parts of radix astragali, 5-15 parts of ground beeltles, 5-15 parts of rhizoma drynariae, 10-20 parts of radix salviae miltiorrhizae, 10-20 parts of rhizoma chuanxiong, 25-35 parts of radix puerariae, 10-20 parts of cortex eucommiae, 10-20 parts of radix angelicae sinensis tablets, 10-20 parts of radix polygoni multiflori preparata, 1-3 parts of neat scorpio, 10-20 parts of herba pyrolae, 10-20 parts of herba sarcandrae, 10-20 parts of concha arcae, 5-15 parts of white mustard seeds, 5-15 parts of rhizoma ligustici, 5-15 parts of roasted rhizoma cimicifugae, 10-20 parts of scirpus yagara ohw, 10-20 parts of rhizoma curcumae, 25-35 parts of caulis spatholobi and 25-35 parts of tender ramulus mori. The traditional Chinese medicine composition mainly treats cervical spondylosis such as cervical bone hyperplasia, cervical intervertebral disc bulging and vertebral artery blood-supply schemia and symptoms such as pain in the neck, the back, the shoulder, the arms and the hands, dumbness, headache, dizziness, nausea and vomiting, tinnitus, deafness, blurred vision which are caused by cervical spondylosis, and the traditional Chinese medicine composition can treat a patient suffering from coronary heart disease simultaneously.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition treating cervical spondylosis.
Background technology
Modern is mostly owing to lacking correct physical training, keep incorrect sitting posture, sleeping position for a long time, surf the Net for a long time, play Mah-Jong, long-term do not get sun and the pollution etc. of food, environment, cause the loss too early of bone calcium and the skewness at skeleton, and with advancing age, constitute software interrup, the degenerations such as the cartilage in joint, intervertebral disc, ligament. Histologically, early stage cartilage fragmentation, the proliferation of chondrocytes. Cartilage surface is longitudinally split, crystallization deposition, osteophytosis. Occurring the thorough destruction of cartilage late period, cartilage hardens, and cartilage disappears and focal osteonecrosis under cartilage. On biochemical change, the content (concentration) of Dan Baiduotang proteoglycan PG declines, and its molecular size and accumulation degree change, and synthesis and the degraded of the size of collagen fiber, arrangement and Matrix protein all occur in that abnormal change. The above all causes neck bone structural damage, regression.
Chinese medicine think kidney governing bones, cervical vertebra be governor vessel institute through part, governor vessel can on follow top, mountain peak, governor's whole body twelve regular channels. Liver governing tendons, muscle Shu Ze joint profit. So the regression of cervical vertebra is cause due to the deficiency of hepatic and renal function.
Current clinical treatment cervical spondylosis, doctor trained in Western medicine relies on operative treatment substantially. One carrys out medical expense height, all causes very big burden to the medical insurance fund of country and the economic expenditure of individual, and two carry out operation risk height, and operative failure rate is also high, brings very big misery to patient. If taking expectant treatment, mainly by means such as traction, acupuncture, physical therapys. Control " mark " and do not control " basis ". And curative effect is also inconspicuous.
The Chinese patent medicine of current clinical treatment cervical spondylosis, one is by externally applied ointment, substantially invalid; Two is that the prescription function of these medicines is mainly expelling wind and removing dampness, dredge the meridian passage by more oral such as Chinese patent medicines such as " JINGFUKANG ", " DAHUOLUO WAN ", " Cao Qinghua capsule ". From the cause of disease that cervical spondylosis produces, these medicines are all less suited the medicine to the illness. It also confirms that these Drug therapy cervical spondylosiss are invalid clinically. Chinese patent medicine " XIANLING GUBAO " is though there being effect of nourishing the liver and kidney, promoting blood circulation to remove obstruction in the collateral, bone and muscle strengthening, but because selecting medicine not smart, though clinic is effective in cure, but the effect for the treatment of cervical spondylosis is general.
Summary of the invention
It is contemplated that overcome the deficiencies in the prior art, it is provided that a kind of Chinese medicine composition treating cervical spondylosis.
In order to achieve the above object, technical scheme provided by the invention is:
The Chinese medicine composition of described treatment cervical spondylosis includes the component of following weight portion:
Radix Astragali 25 35 parts, Eupolyphaga Seu Steleophaga 5 15 parts, Rhizoma Drynariae 5 15 parts, Radix Salviae Miltiorrhizae 10 20 parts, Rhizoma Chuanxiong 10 20 parts, RADIX PUERARIAE 25 35 parts, Cortex Eucommiae 10 20 parts, sheet Radix Angelicae Sinensis 10 20 parts, Radix Polygoni Multiflori Preparata 10 20 parts, clean Scorpio 13 parts, Herba Pyrolae 10 20 parts, Herba Sarcandrae 10 20 parts, Concha Arcae 10 20 parts, Semen Sinapis Albae 5 15 parts, western Rhizoma Ligustici 5 15 parts, fries Rhizoma Cimicifugae 5 15 parts, cyperus iria L. rhizoma scirpi 10 20 parts, Rhizoma Curcumae 10 20 parts, Caulis Spatholobi 25 35 parts, RAMULUS MORI 25 35 parts.
Preferably, described Chinese medicine composition includes the component of following weight portion:
Radix Astragali 28 32 parts, Eupolyphaga Seu Steleophaga 8 12 parts, Rhizoma Drynariae 8 12 parts, Radix Salviae Miltiorrhizae 13 17 parts, Rhizoma Chuanxiong 13 17 parts, RADIX PUERARIAE 28 32 parts, Cortex Eucommiae 13 17 parts, sheet Radix Angelicae Sinensis 13 17 parts, Radix Polygoni Multiflori Preparata 13 17 parts, clean Scorpio 1.5 2.5 parts, Herba Pyrolae 13 17 parts, Herba Sarcandrae 13 17 parts, Concha Arcae 13 17 parts, Semen Sinapis Albae 7 13 parts, western Rhizoma Ligustici 7 13 parts, fries Rhizoma Cimicifugae 7 13 parts, cyperus iria L. rhizoma scirpi 13 17 parts, Rhizoma Curcumae 13 17 parts, Caulis Spatholobi 28 32 parts, RAMULUS MORI 28 32 parts.
It is highly preferred that described Chinese medicine composition includes the component of following weight portion:
Radix Astragali 30 parts, Eupolyphaga Seu Steleophaga 10 parts, Rhizoma Drynariae 10 parts, Radix Salviae Miltiorrhizae 15 parts, Rhizoma Chuanxiong 15 parts, RADIX PUERARIAE 30 parts, Cortex Eucommiae 15 parts, sheet Radix Angelicae Sinensis 15 parts, Radix Polygoni Multiflori Preparata 15 parts, clean Scorpio 2 parts, Herba Pyrolae 15 parts, Herba Sarcandrae 15 parts, Concha Arcae 15 parts, Semen Sinapis Albae 10 parts, western Rhizoma Ligustici 10 parts, fries Rhizoma Cimicifugae 10 parts, cyperus iria L. rhizoma scirpi 15 parts, Rhizoma Curcumae 15 parts, Caulis Spatholobi 30 parts, RAMULUS MORI 30 parts.
Pharmaceutical composition of the present invention preparation method can make various dosage form routinely, it is preferred to concentrated pill.
The invention will be further described below:
Chinese medicine composition of the present invention has QI invigorating dredging DU Meridian, nourishing liver and kidney, blood circulation promoting and dispersing pathogen accumulation, effect of relaxing muscles and tendons blood stasis dispelling. QI and blood is vigorous, it is logical to superintend and direct, bone strong, muscle relaxes, knot dissipates, numbness disappears, and recovers.
From modern pharmacology analysis, described Chinese medicine composition has thrombolytic, improves blood circulation, increases heart and brain blood flow, improves the function of chondrocyte, postpones the regression of osteocyte, promotes cartilage-derived growth, reparation. The position of hyperosteogeny can be softened, the calcium in more contiguous hypertrophy osseous tissues can be transferred out the destruction position depositing to cartilage. To better meet chondrogenetic needs. While regulating bone calcium reasonable layout, moreover it is possible to make the calcium in surrounding tissue and blood also can obtain reasonable layout. Described Chinese medicine composition can also improve the content of serum zinc and zinc/copper ratio to accelerate cartilage-derived growth and calcification process. Promote that osteocyte is ripe and secretes permeability mucopolysaccharide and collagen stroma, and promote calcium salt deposition on collagen stroma, form bone brief summary. Substantially promoting fibroblast to be converted to scale shape direction by prismatic, cell concentration increases, and collage synthesis secretion increases, and accelerates the process that fibroblast is substituted by osseous tissue. Meanwhile, described Chinese medicine composition also has raising bone mineral density, osteoporosis, improves desmoplastic effect.
The cervical spondylosis such as Chinese medicine composition of the present invention cures mainly hyperosteogeny of cervical vertebra, intervertebral disc of cervical vertebra is dashed forward, bulging disease, vertebral artery insufficiency. And the pain of consequent item, the back of the body, shoulder, arm, hands, numb, headache, dizzy, nausea and vomiting, tinnitus, deafness, the symptom such as blurring of vision. For suffering from the patient of coronary heart disease, described Chinese medicine composition can be treated simultaneously, can treat rib inflammation simultaneously.
Owing to described Chinese medicine composition is without obvious toxic-side effects, it is possible to regulate the distribution of internal bone calcium, so can act also as the long-term taking health product of prevention cervical spine degeneration.
Detailed description of the invention
Embodiment 1
The Chinese medicine composition of described treatment cervical spondylosis includes the component of following weight portion:
Radix Astragali 30 parts, Eupolyphaga Seu Steleophaga 10 parts, Rhizoma Drynariae 10 parts, Radix Salviae Miltiorrhizae 15 parts, Rhizoma Chuanxiong 15 parts, RADIX PUERARIAE 30 parts, Cortex Eucommiae 15 parts, sheet Radix Angelicae Sinensis 15 parts, Radix Polygoni Multiflori Preparata 15 parts, clean Scorpio 2 parts, Herba Pyrolae 15 parts, Herba Sarcandrae 15 parts, Concha Arcae 15 parts, Semen Sinapis Albae 10 parts, western Rhizoma Ligustici 10 parts, fries Rhizoma Cimicifugae 10 parts, cyperus iria L. rhizoma scirpi 15 parts, Rhizoma Curcumae 15 parts, Caulis Spatholobi 30 parts, RAMULUS MORI 30 parts.
Embodiment 2
The Chinese medicine composition of described treatment cervical spondylosis includes the component of following weight portion:
Radix Astragali 25 parts, Eupolyphaga Seu Steleophaga 15 parts, Rhizoma Drynariae 5 parts, Radix Salviae Miltiorrhizae 20 parts, Rhizoma Chuanxiong 10 parts, RADIX PUERARIAE 35 parts, Cortex Eucommiae 10 parts, sheet Radix Angelicae Sinensis 20 parts, Radix Polygoni Multiflori Preparata 10 parts, clean Scorpio 3 parts, Herba Pyrolae 10 parts, Herba Sarcandrae 20 parts, Concha Arcae 10 parts, Semen Sinapis Albae 15 parts, western Rhizoma Ligustici 5 parts, fries Rhizoma Cimicifugae 15 parts, cyperus iria L. rhizoma scirpi 10 parts, Rhizoma Curcumae 20 parts, Caulis Spatholobi 25 parts, RAMULUS MORI 35 parts.
Embodiment 3
The Chinese medicine composition of described treatment cervical spondylosis includes the component of following weight portion:
Radix Astragali 35 parts, Eupolyphaga Seu Steleophaga 5 parts, Rhizoma Drynariae 15 parts, Radix Salviae Miltiorrhizae 10 parts, Rhizoma Chuanxiong 20 parts, RADIX PUERARIAE 25 parts, Cortex Eucommiae 20 parts, sheet Radix Angelicae Sinensis 10 parts, Radix Polygoni Multiflori Preparata 20 parts, clean Scorpio 1 part, Herba Pyrolae 20 parts, Herba Sarcandrae 10 parts, Concha Arcae 20 parts, Semen Sinapis Albae 5 parts, western Rhizoma Ligustici 15 parts, fries Rhizoma Cimicifugae 5 parts, cyperus iria L. rhizoma scirpi 20 parts, Rhizoma Curcumae 10 parts, Caulis Spatholobi 35 parts, RAMULUS MORI 25 parts.
Embodiment 4
The tentative commodity of Chinese medicine composition of the present invention " neck moves back multiple " by name, the hundreds of remaining example of Patients with Cervical Spondylopathy is treated in rough estimates altogether, and overall efficiency is up to 100%, and clinical symptoms complete remission rate is up to more than 80%. If actually can adhere to, the long period takes medicine, and is substantially attained by symptom complete incidence graph. (because cervical spondylosis is the degeneration of a kind of skeleton, so not-so-practical with cure rate). Following patient's taking dose is that every day one is secondary, and the proportions of each components in mass portion, unit are g.
Model case one: first, man, 62 years old. Within 2012, once because suffering from the prominent bulging disease of lumbar intervertebral disc, in Xiang Ya hospital of Hunan Province, attached hospital's spinal surgery carries out lumbar vertebra multi-joint intervertebral disc local excision fixation. But postoperative because of infect cause nephrotic syndrome, recover by therapy of combining Chinese and Western medicine. The second half year in 2014, patient suffers from again intervertebral disc protrusion of cervical vertebra disease and part bulging causes patient's item, the back of the body, shoulder, brachialgia hardship extremely, and head term can not rotate, hands can not hold thing, live extremely inconvenient, after the refined attached hospital admission in Hunan, make above-mentioned medical diagnosis on disease through nuclear magnetic resonance, NMR. Patient's cervical region of announcement still needs to operative treatment. Because patient's fear is performed the operation again, turn and ask Chinese traditional treatment. Through clothes " neck moves back multiple " after February, the state of an illness is substantially alleviated and adheres to sending silk banner one side with table gratitude. Now healthy living always.
Model case two: second, female, 55 years old. 2013, patient, because of substantially dizzy, depending on dizzy turn of thing, nausea and vomiting, it is impossible to get up, slightly moved and then swoons very, companioned with headache. Through Changsha one hospital, nuclear magnetic resonance diagnosis is, cervical vertebra degeneration, intervertebral disc protrusion of cervical vertebra disease. Patient, because Western medicine multiple medicines is had allergies, turns and asks Chinese traditional treatment. Take " neck moves back multiple " (tentatively titled) January and heal.
Model case three: the third, man, 65 years old. 2015, patient was because of headache as splits, and nausea and vomiting even can not be combed one's hair, term by term combination, the back of the body, shoulder, arm pain, accompanied tinnitus, deafness.Through Annex III institute of Xiang Ya hospital, nuclear magnetic resonance diagnosis is cervical vertebra degeneration. Recommend heal clothes " neck moves back multiple " (tentatively titled) February by other people.
Model case four: fourth, female, 54 years old. Within 2013, patient causes left hand refer to pain because of the left shoulder back of the body and left upper extremity, is scapulohumeral periarthritis, channel in locality diagnosis, and the Chinese traditional treatment several months does not heal, and is cervical vertebra degeneration, prolapse of cervical intervertebral disc by the diagnosis of Changsha four examination in hospital. Recommend heal clothes " neck moves back multiple " (tentatively titled) January by other people.
Currently, country advocates innovative economy and supply side reform energetically. If this medicine can success granted country new Chinese medicine patent of invention. Produce in batches. More patient then can be allowed to benefit, alleviate the misery of patient. Also the financial burden of medical insurance and patient can be alleviated. Pharmaceutical factory of traditional Chinese medicine's transition and upgrade that some are old can also be made. Also the peasant of a collection of remote mountain areas can be made to get rich on the spot. Be one, the secondary industry and the tertiary industry pulls simultaneously. Make contributions for country.
Claims (3)
1. the Chinese medicine composition treating cervical spondylosis, it is characterised in that described Chinese medicine composition includes the component of following weight portion:
Radix Astragali 25 35 parts, Eupolyphaga Seu Steleophaga 5 15 parts, Rhizoma Drynariae 5 15 parts, Radix Salviae Miltiorrhizae 10 20 parts, Rhizoma Chuanxiong 10 20 parts, RADIX PUERARIAE 25 35 parts, Cortex Eucommiae 10 20 parts, sheet Radix Angelicae Sinensis 10 20 parts, Radix Polygoni Multiflori Preparata 10 20 parts, clean Scorpio 13 parts, Herba Pyrolae 10 20 parts, Herba Sarcandrae 10 20 parts, Concha Arcae 10 20 parts, Semen Sinapis Albae 5 15 parts, western Rhizoma Ligustici 5 15 parts, fries Rhizoma Cimicifugae 5 15 parts, cyperus iria L. rhizoma scirpi 10 20 parts, Rhizoma Curcumae 10 20 parts, Caulis Spatholobi 25 35 parts, RAMULUS MORI 25 35 parts.
2. compositions as claimed in claim 1, it is characterised in that described Chinese medicine composition includes the component of following weight portion:
Radix Astragali 28 32 parts, Eupolyphaga Seu Steleophaga 8 12 parts, Rhizoma Drynariae 8 12 parts, Radix Salviae Miltiorrhizae 13 17 parts, Rhizoma Chuanxiong 13 17 parts, RADIX PUERARIAE 28 32 parts, Cortex Eucommiae 13 17 parts, sheet Radix Angelicae Sinensis 13 17 parts, Radix Polygoni Multiflori Preparata 13 17 parts, clean Scorpio 1.5 2.5 parts, Herba Pyrolae 13 17 parts, Herba Sarcandrae 13 17 parts, Concha Arcae 13 17 parts, Semen Sinapis Albae 7 13 parts, western Rhizoma Ligustici 7 13 parts, fries Rhizoma Cimicifugae 7 13 parts, cyperus iria L. rhizoma scirpi 13 17 parts, Rhizoma Curcumae 13 17 parts, Caulis Spatholobi 28 32 parts, RAMULUS MORI 28 32 parts.
3. compositions as claimed in claim 2, it is characterised in that described Chinese medicine composition includes the component of following weight portion:
Radix Astragali 30 parts, Eupolyphaga Seu Steleophaga 10 parts, Rhizoma Drynariae 10 parts, Radix Salviae Miltiorrhizae 15 parts, Rhizoma Chuanxiong 15 parts, RADIX PUERARIAE 30 parts, Cortex Eucommiae 15 parts, sheet Radix Angelicae Sinensis 15 parts, Radix Polygoni Multiflori Preparata 15 parts, clean Scorpio 2 parts, Herba Pyrolae 15 parts, Herba Sarcandrae 15 parts, Concha Arcae 15 parts, Semen Sinapis Albae 10 parts, western Rhizoma Ligustici 10 parts, fries Rhizoma Cimicifugae 10 parts, cyperus iria L. rhizoma scirpi 15 parts, Rhizoma Curcumae 15 parts, Caulis Spatholobi 30 parts, RAMULUS MORI 30 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610238227.9A CN105664068A (en) | 2016-04-18 | 2016-04-18 | Traditional Chinese medicine composition for treating cervical spondylosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610238227.9A CN105664068A (en) | 2016-04-18 | 2016-04-18 | Traditional Chinese medicine composition for treating cervical spondylosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105664068A true CN105664068A (en) | 2016-06-15 |
Family
ID=56309225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610238227.9A Pending CN105664068A (en) | 2016-04-18 | 2016-04-18 | Traditional Chinese medicine composition for treating cervical spondylosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105664068A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102988639A (en) * | 2012-10-27 | 2013-03-27 | 王勤 | Medicament for treating cervical spondylosis and preparation method of medicament |
-
2016
- 2016-04-18 CN CN201610238227.9A patent/CN105664068A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102988639A (en) * | 2012-10-27 | 2013-03-27 | 王勤 | Medicament for treating cervical spondylosis and preparation method of medicament |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872299B (en) | Medicine compound for treating osteoporosis and osteoporosis fracture | |
| CN101284073B (en) | Combination medicine for curing the hoary hair | |
| CN104147075A (en) | Traditional Chinese medicinal composition, and preparation method and pharmaceutical use thereof | |
| CN101507783B (en) | Medicinal wine capable of treating lumbar disc protrusion | |
| CN101664480B (en) | Chinese herbal medicine medicament for treating hyperosteogeny | |
| CN101485774A (en) | Oral liquid for treating osteoporosis | |
| CN103800489B (en) | A kind of Chinese medicinal liquor for the treatment of cervical spondylosis and preparation method thereof | |
| CN1330337C (en) | Pure Chinese medicine for treating protrasion of lumbar intervertebral disc and osteoporosis and preparation method | |
| CN102283938B (en) | Medicinal liquor for treating primary osteoarthritis and cervical and lumbar disc herniation, and preparation method thereof | |
| CN102100759A (en) | Traditional Chinese medicine composition with functions of tonifying liver and kidney and treating hyperosteogeny | |
| CN102274293A (en) | Muscle and bone relaxing capsules | |
| CN102091200B (en) | Chinese medicinal preparation for treating bone fracture | |
| CN105664068A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN100473402C (en) | Medicine for treating protrusion of intervetebral disc and cervical vertebra disease | |
| CN1255126C (en) | Medicinal prescription for treating aseptic necrosis of femur head | |
| CN1977934A (en) | Medicinal liquor for treating cervix vertebra disease and lumbar disc protrusion and its preparing method | |
| CN102988659A (en) | Hyperosteogeny formula and application method thereof | |
| CN102198246B (en) | Chinese medicinal preparation for treating bone diseases | |
| CN105688059A (en) | Traditional Chinese medicine preparation with folium artemisiae argyi for treating osteoproliferation through external application | |
| CN109999107A (en) | A kind of atrophic debility of bones ball for treating senile osteoporosis | |
| CN104666581A (en) | Health care product for enhancing bone density and improving immunity and preparation method of health care product | |
| CN104324319A (en) | Health-caring product promoting health of bone joint | |
| CN103877490A (en) | Traditional-Chinese-medicine preparation for treating lumbar disc herniation and preparation method thereof | |
| CN103860763A (en) | Chinese patent medicine for treating osteoarthropathy | |
| CN104189102B (en) | A kind of Chinese medicine composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160615 |
|
| RJ01 | Rejection of invention patent application after publication |